FDA Drug Application (061653) for TETREX by BRISTOL

Back to FDA Applications sponsored by BRISTOL

Application Number061653
Product Number001
FormCAPSULE;ORAL
DosageEQ 100MG HCL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTETREX
Active IngredientTETRACYCLINE PHOSPHATE COMPLEX



Back to FDA Applications sponsored by BRISTOL